Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Current Leases (2023 - 2025)

Beta Bionics (BBNX) has disclosed Current Leases for 3 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 26.75% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 26.75% year-over-year, with the annual reading at $1.9 million for FY2025, 26.75% up from the prior year.
  • Current Leases hit $1.9 million in Q4 2025 for Beta Bionics, down from $2.0 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.0 million in Q3 2025 to a low of $1.2 million in Q4 2023.
  • Historically, Current Leases has averaged $1.6 million across 3 years, with a median of $1.5 million in 2024.
  • Biggest five-year swings in Current Leases: grew 24.92% in 2024 and later rose 26.75% in 2025.
  • Year by year, Current Leases stood at $1.2 million in 2023, then increased by 24.92% to $1.5 million in 2024, then grew by 26.75% to $1.9 million in 2025.
  • Business Quant data shows Current Leases for BBNX at $1.9 million in Q4 2025, $2.0 million in Q3 2025, and $1.5 million in Q2 2025.